EVAX – evaxion biotech a/s - american depositary share (US:NASDAQ)

News

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Evaxion announce 2026 financial calendar
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 [Yahoo! Finance]
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Evaxion announces business update and third quarter 2025 financial results
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com